| Views | |
|---|---|
| A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations | 234 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations | 3 | 10 | 15 | 5 | 1 | 1 | 0 |
| Views | |
|---|---|
| 1-s2.0-S2211124721008500-main.pdf | 288 |
